Independent, sound science clearly shows that taking acetaminophen does not cause autism,” a Kenvue spokesperson told Barron’s.

Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn’t offer fresh evidence that could be used by plaintiffs to sue the maker of Tylenol for its alleged link to autism.

President Donald Trump is set to speak today on how Tylenol may be linked to autism. Here's when, who makes Tylenol, and about the NJ company Kenvue.

Kenvue shares rose 6% in premarket trading on Tuesday, set to rebound from a record low hit in the previous session as U.S. President Donald Trump linked its popular pain medication Tylenol to autism.

Shares may be rising because investors expected the White House to announce stricter regulations on the medication, Citi analysts said.

President Donald Trump created a potentially existential crisis for Tylenol maker Kenvue Inc. with just three words about the company’s most-recognized product: “don’t take it.”

Trump announced that Tylenol could cause autism on Sept. 22, 2025, during a press conference at the White House. A Kenvue Inc. (the company that owns Tylenol) spokesperson confirmed that a snarky statement being shared in social posts was not the company's official response.

President Donald Trump warned pregnant women not to take Tylenol citing, without evidence, that it causes autism. Who owns the painkiller company?

The Trump administration warned about the risk of use during pregnancy, which the company disputes.

Trump’s warnings about the unproven link between Tylenol use during pregnancy to autism in children risks reinvigorating a barrage of litigation over the issue that the company has sought to put behind it.